|Quantity Discounts||1 - 9999|
|1 - 9999|
|1 - 9999|
Everyone can count on death and taxes. If you manufacture drugs, devices, biologics or diagnostics, here’s another thing to count on: a visit from the FDA.
A re-energized FDA has been hiring and training hundreds of additional investigators. Now they are fanning out into the field. Next thing you know, one of them will be knocking on your door.
What are their marching orders? Where will these recent recruits start poking around first, looking for soft spots in your manufacturing operation?
Dr. Robert Schiff, a top auditing consultant, knows where.
He makes it his business to stay a step ahead of the FDA. A certified quality auditor and fellow of the Regulatory Affairs Professional Society, he’s the next best thing to being a “fly on the wall” inside FDA’s investigator training classes.
Now, Dr. Schiff has compiled a list of the 10 most common cGMP violations in every FDA-regulated company ... and how to remedy them before an eager-beaver investigator knocks on your door.
Mark your calendar for Wednesday, March 31, 2010, when Dr. Schiff makes an exclusive appearance on your desktop screen, courtesy of FDAnews. In a fast-paced 90-minute webinar, he’ll disclose problem areas and arm you in advance with eight strategies to make sure you get a clean report:
Everyone in your organization with a role in cGMPs deserves to take part in this event — and they can do so, at a cost that won’t break your budget. You pay a single low registration fee per facility, regardless of how many participate. So spread the word.
Have questions? Simply submit them via email for answers by the time the session ends.
Consider the costs of flunking an examination … think of the weeks spent on remediation and lost staff time ... even manufacturing downtime is a possibility. Weigh those costs against the 90 minutes you’ll spend with Dr. Schiff. It could be the most important 90 minutes of the year.
Robert Schiff, Ph.D., is CEO of Schiff & Company, a regulatory affairs, compliance and clinical research organization he founded in 1982 following stints with companies including Warner-Lambert, Hoffmann-La Roche, J. T. Baker (Richardson-Vicks), the Hyland Division of Travenol Laboratories (Baxter), and as an assistant professor at Tufts University Schools of Medicine and Dental Medicine. A certified quality auditor and fellow of the Regulatory Affairs Professional Society, Dr. Schiff has authored more than 50 publications and holds several patents on medical products.
|Date:||April 5–23, 2010
|Location:||Your office or conference room (no need to travel!)|
Gather your team for maximum benefit! Your investment is for one dial-in.
We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.
Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600
Registrations may not be cancelled. Please contact customer service to make any substitutions.
Interested in Becoming a Speaker?
We're always looking for industry leaders eager to share their expertise at an FDAnews audioconference, webinar or physical conference. Our seasoned speaker community includes executives in the pharmaceutical, medical device and clinical trial industries, regulatory affairs, quality control, compliance, healthcare and academia, as well as several former — and current — top FDA officials. Click here to complete our speaker opportunity form and have a representative contact you about future opportunities.
Copyright ©2018. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing